XOM

165.15

+2.47%↑

CVX

206.77

+0.92%↑

SHEL.US

91.2

+0.51%↑

TTE.FR

77.21

+1.42%↑

COPNY

129.36

+1.59%↑

XOM

165.15

+2.47%↑

CVX

206.77

+0.92%↑

SHEL.US

91.2

+0.51%↑

TTE.FR

77.21

+1.42%↑

COPNY

129.36

+1.59%↑

XOM

165.15

+2.47%↑

CVX

206.77

+0.92%↑

SHEL.US

91.2

+0.51%↑

TTE.FR

77.21

+1.42%↑

COPNY

129.36

+1.59%↑

XOM

165.15

+2.47%↑

CVX

206.77

+0.92%↑

SHEL.US

91.2

+0.51%↑

TTE.FR

77.21

+1.42%↑

COPNY

129.36

+1.59%↑

XOM

165.15

+2.47%↑

CVX

206.77

+0.92%↑

SHEL.US

91.2

+0.51%↑

TTE.FR

77.21

+1.42%↑

COPNY

129.36

+1.59%↑

Search

Ultrapar Participacoes SA

Uždarymo kaina

SektoriusEnergijos sektorius

5.27 1.15

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

5.1

Max

5.27

Pagrindiniai rodikliai

By Trading Economics

Pajamos

383M

514M

Pardavimai

1.5B

39B

P/E

Sektoriaus vid.

10.978

66.822

Dividendų pajamingumas

6.4

Pelno marža

1.334

Darbuotojai

10,947

EBITDA

-491M

1.8B

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+3.85% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

6.40%

3.56%

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-32M

5.3B

Ankstesnė atidarymo kaina

4.12

Ankstesnė uždarymo kaina

5.27

Naujienos nuotaikos

By Acuity

50%

50%

57 / 137 reitingas Energy

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Strong Bearish Evidence

Ultrapar Participacoes SA Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-23 23:47; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

2026-03-23 22:55; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

2026-03-23 21:51; UTC

Įsigijimai, susijungimai, perėmimai

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

2026-03-23 23:59; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-03-23 23:59; UTC

Rinkos pokalbiai

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

2026-03-23 23:50; UTC

Rinkos pokalbiai

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

2026-03-23 23:37; UTC

Rinkos pokalbiai

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

2026-03-23 22:42; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Global Equities Roundup: Market Talk

2026-03-23 22:42; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

2026-03-23 22:40; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

2026-03-23 22:23; UTC

Rinkos pokalbiai

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

2026-03-23 22:22; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

2026-03-23 22:21; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

2026-03-23 22:21; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

2026-03-23 22:20; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

2026-03-23 22:20; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

2026-03-23 22:19; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

2026-03-23 22:19; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

2026-03-23 22:18; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

2026-03-23 22:15; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

2026-03-23 22:08; UTC

Rinkos pokalbiai

Ebos Needs to Reset Its Gearing Targets -- Market Talk

2026-03-23 21:42; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-03-23 21:42; UTC

Rinkos pokalbiai

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

2026-03-23 21:32; UTC

Uždarbis

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

2026-03-23 21:32; UTC

Uždarbis

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

2026-03-23 21:32; UTC

Uždarbis

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

2026-03-23 21:10; UTC

Svarbiausios naujienos

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

2026-03-23 20:50; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2026-03-23 20:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2026-03-23 20:50; UTC

Rinkos pokalbiai
Uždarbis
Svarbiausios naujienos

Basic Materials Roundup: Market Talk

Akcijų palyginimas

Kainos pokytis

Ultrapar Participacoes SA Prognozė

Kainos tikslas

By TipRanks

3.85% į viršų

12 mėnesių prognozė

Vidutinis 5.4 USD  3.85%

Aukščiausias 5.4 USD

Žemiausias 5.4 USD

Remiantis 1 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Ultrapar Participacoes SA kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

1 ratings

0

Pirkti

1

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

N/A / 3.1341Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Strong Bearish Evidence

Vidutinės trukmės periodas

Weak Bearish Evidence

Ilgalaikis periodas

Weak Bearish Evidence

Rinkos nuotaikos

By Acuity

57 / 137 reitingas Energijos sektorius

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Vidutinis

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Ultrapar Participacoes SA

Ultrapar Participações S.A., through its subsidiaries, operates in the energy and infrastructure business in Brazil. The company distributes liquefied petroleum gas to residential, commercial, and industrial consumers. It also operates Stella, a technology platform that connects renewable electric power generators and customers; and transports compressed natural gas. In addition, the company is involved in the distribution and marketing of gasoline, ethanol, diesel, fuel oil, kerosene, natural gas for vehicles, and lubricants; and holds AmPm convenience stores and provides Jet Oil lubricant services. Further, it operates liquid bulk storage terminals. Additionally, the company offers digital payments services, combining the abastece aí app and the loyalty program Km de Vantagens. It also exports its products and services to customers in Europe, the United States, Canada, other Latin American countries, Asia, and internationally. The company was founded in 1937 and is headquartered in São Paulo, Brazil.
help-icon Live chat